NHS framework agreement to supply the North of England — Dose Banded Cytotoxic Medicines. The framework will commence on 01.12.2016 for a period of 2 years until 30.11.2018, with options to extend for up to a further 24 months.
Please refer to the Invitation to offer, for a list of Purchasing Points. The framework agreement is intended for use by the NHS in the North East, North West, Yorkshire and The Humber Regions and London (Rituximab only).The framework may also be used by private sector contractors and agents working on behalf of the above.
The framework agreement is intended for use by the Department of Health, Public
Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. A list can be supplied on request.
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. A list can be supplied on request.